Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH‐HD2002 trial |
| |
| Authors: | L. Kurch,D. Hasenclever,R. Kluge,T. Georgi,L. Tchavdarova,M. Golombeck,O. Sabri,A. Eggert,W. Brenner,K.W. Sykora,F.M. Bengel,C. Rossig,D. K rholz,M. Sch fers,T. Feuchtinger,P. Bartenstein,R.A. Ammann,T. Krause,C. Urban,R. Aigner,S. Gattenl hner,W. Klapper,C. Mauz‐K rholz |
| |
| Affiliation: | L. Kurch,D. Hasenclever,R. Kluge,T. Georgi,L. Tchavdarova,M. Golombeck,O. Sabri,A. Eggert,W. Brenner,K.W. Sykora,F.M. Bengel,C. Rossig,D. Körholz,M. Schäfers,T. Feuchtinger,P. Bartenstein,R.A. Ammann,T. Krause,C. Urban,R. Aigner,S. Gattenlöhner,W. Klapper,C. Mauz‐Körholz |
| |
| Abstract: | |
| |
| Keywords: | F18‐FDG‐PET GPOH‐HD2002 trial pediatric Hodgkin lymphoma (PHL) qPET quantitative Deauville score (qDS) visual Deauville score (vDS) |
|
|
